Alvotech (ALVO)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$3.55
+7.42%
Mkt Cap $1.05B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 18, 2026 | $162.19M | $173.20M | +6.79% | -$0.01 | -$0.37 | -6334.78% | — | — |
| Q4 2025 Nov 12, 2025 | $164.93M | $113.95M | -30.91% | $0.05 | -$0.02 | -140.00% | — | — |
| Q3 2025 Aug 13, 2025 | $155.55M | $173.24M | +11.37% | -$0.26 | $0.14 | +153.85% | — | — |
| Q2 2025 May 7, 2025 | $120.51M | $132.76M | +10.17% | -$0.17 | $0.35 | +305.88% | — | — |
| Q1 2025 Mar 26, 2025 | $97.99M | $151.21M | +54.31% | -$0.39 | -$0.24 | +38.46% | — | — |
| Q4 2024 Nov 13, 2024 | $85.00M | $489.68M | +476.10% | -$0.06 | $0.19 | +401.59% | — | — |
| Q3 2024 Aug 15, 2024 | $84.00M | $198.75M | +136.61% | -$0.28 | $0.28 | +200.00% | — | — |
| Q2 2024 May 21, 2024 | — | $12.43M | — | -$0.08 | -$0.89 | -972.29% | — | — |
| Q1 2024 Mar 20, 2024 | $68.00M | $53.39M | -21.49% | $0.15 | -$1.22 | -913.33% | — | — |
| Q4 2023 Nov 28, 2023 | $43.00M | $17.79M | -58.63% | -$0.29 | -$0.82 | -182.76% | — | — |
| Q3 2023 Aug 30, 2023 | $42.00M | $4.39M | -89.55% | -$0.14 | -$0.43 | -207.14% | — | — |
| Q2 2023 May 19, 2023 | — | $15.86M | — | — | -$0.33 | — | — | — |
| Q1 2023 Mar 1, 2023 | — | $23.86M | — | — | -$1.29 | — | — | — |
| Q4 2022 Nov 16, 2022 | — | $19.05M | — | — | -$0.04 | — | — | — |
| Q3 2022 Sep 1, 2022 | — | $39.67M | — | — | -$0.54 | — | — | — |
| Q2 2022 May 16, 2022 | — | $452.00K | — | — | -$0.32 | — | — | — |
| Q1 2022 Mar 30, 2022 | — | $34.76M | — | — | $1.28 | — | — | — |
| Q4 2021 Nov 15, 2021 | — | $536.00K | — | — | -$0.41 | — | — | — |
| Q3 2021 Aug 16, 2021 | — | $1.18M | — | — | -$0.01 | — | — | — |
| Q2 2021 May 20, 2021 | — | $1.18M | — | — | $0.23 | — | — | — |